Published on: August 14, 2017 at 10:00AM Condition: Advance Care PlanningInterventions: Behavioral: video; Behavioral: usual careSponsor: University of Alabama at BirminghamNot yet recruiting - verified...
Clinical Trials
Published on: August 11, 2017 at 10:00AM Condition: Colorectal CancerIntervention: Other: ObservationalSponsors: University of Southern Denmark; Danish Cancer SocietyCompleted - verified August 2017...
Published on: August 10, 2017 at 10:00AM Condition: Cervical CancerInterventions: Radiation: Radiation; Radiation: brachytherapy; Drug: Cisplatin; Other: HyperthermiaSponsor: University of Erlangen-Nürnberg Medical SchoolRecruiting...
Published on: August 10, 2017 at 10:00AM Condition: Cervical CancerInterventions: Radiation: Radiation; Radiation: brachytherapy; Drug: Cisplatin; Other: HyperthermiaSponsor: University of Erlangen-Nürnberg Medical SchoolRecruiting...
Published on: August 10, 2017 at 10:00AM Condition: Cervical CancerInterventions: Radiation: Radiation; Radiation: brachytherapy; Drug: Cisplatin; Other: HyperthermiaSponsor: University of Erlangen-Nürnberg Medical SchoolRecruiting...
Published on: August 10, 2017 at 10:00AM Condition: Cervical CancerInterventions: Radiation: Radiation; Radiation: brachytherapy; Drug: Cisplatin; Other: HyperthermiaSponsor: University of Erlangen-Nürnberg Medical SchoolRecruiting...
Published on: August 10, 2017 at 10:00AM Condition: Cervical CancerInterventions: Radiation: Radiation; Radiation: brachytherapy; Drug: Cisplatin; Other: HyperthermiaSponsor: University of Erlangen-Nürnberg Medical SchoolRecruiting...
Published on: August 11, 2017 at 10:00AM Conditions: Metastasis Spine; Metastasis to BoneIntervention: Device: OsteoCool™ RF AblationSponsor: MedtronicNeuroNot yet recruiting - verified...
Published on: August 09, 2017 at 10:00AM Conditions: Solid Tumor; LymphomaInterventions: Drug: MK-2118; Biological: PembrolizumabSponsor: Merck Sharp & Dohme Corp.Not yet recruiting...
Published on: August 09, 2017 at 10:00AM Conditions: Solid Tumor; LymphomaInterventions: Drug: MK-2118; Biological: PembrolizumabSponsor: Merck Sharp & Dohme Corp.Not yet recruiting...
Published on: August 09, 2017 at 10:00AM Conditions: Solid Tumor; LymphomaInterventions: Drug: MK-2118; Biological: PembrolizumabSponsor: Merck Sharp & Dohme Corp.Not yet recruiting...
Published on: August 09, 2017 at 10:00AM Conditions: Solid Tumor; LymphomaInterventions: Drug: MK-2118; Biological: PembrolizumabSponsor: Merck Sharp & Dohme Corp.Not yet recruiting...
Published on: August 09, 2017 at 10:00AM Conditions: Solid Tumor; LymphomaInterventions: Drug: MK-2118; Biological: PembrolizumabSponsor: Merck Sharp & Dohme Corp.Not yet recruiting...
Published on: August 09, 2017 at 12:00PM Condition: Cancer PreventionIntervention: Behavioral: Getting Ahead in a Just-Gettin'-By WorldSponsor: Case Comprehensive Cancer CenterNot...
Published on: August 10, 2017 at 12:00PM Condition: Breast CancerIntervention: Drug: DS-8201aSponsors: Daiichi Sankyo, Inc.; Daiichi Sankyo Co., Ltd.Not yet recruiting - verified...
Published on: August 11, 2017 at 12:00PM Condition: CancerIntervention: Sponsor: National Cancer Institute (NCI)Not yet recruiting - verified July 20,...
Published on: August 11, 2017 at 12:00PM Condition: CancerIntervention: Sponsor: National Cancer Institute (NCI)Not yet recruiting - verified July 20,...
Published on: August 09, 2017 at 12:00PM Conditions: Castration Resistant Prostatic Cancer; Metastatic Prostate CancerInterventions: Drug: Pembrolizumab; Drug: ChemotherapySponsor: University of California, San FranciscoNot yet recruiting...
